India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture



Summary



GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the India In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the India In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Span Diagnostics Ltd. and others.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the India In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In India 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018 18
3.3 In Vitro Diagnostics Market, India, Revenue Mix ($m), 2011 20
3.4 In Vitro Diagnostics Market, India, Category Contribution (%), 2011 21
3.5 In Vitro Diagnostics, India, Company Share (2010-2011) 28
4 Clinical Chemistry In India 30
4.1 Clinical Chemistry, Market Segmentation 30
4.2 Clinical Chemistry Market, India, Revenue Mix ($m), 2011 31
4.3 Clinical Chemistry Market, India, Segment Contribution (%), 2011 32
4.4 Clinical Chemistry Overall Revenue, (2004-2018) 33
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 37
4.4.2 Urine Analysis, Revenue (2004-2018) 41
4.5 Clinical Chemistry Distribution Share (2010-2011) 43
4.6 Clinical Chemistry, India, Company Share (2010-2011) 44
5 Genetic Testing In India 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, India, Revenue Mix ($m), 2011 47
5.3 Genetic Testing Market, India, Segment Contribution (%), 2011 48
5.4 Genetic Testing Overall Revenue, (2004-2018) 49
5.5 Genetic Testing Distribution Share (2010-2011) 53
5.6 Genetic Testing, India, Company Share (2010-2011) 54
6 Haematology In India 56
6.1 Haematology Market, Market Segmentation 56
6.2 Haematology Market, India, Revenue Mix ($m), 2011 57
6.3 Haematology Market, India, Segment Contribution (%), 2011 58
6.4 Haematology Overall Revenue, (2004-2018) 59
6.4.1 Haematology Reagents, Revenue (2004-2018) 63
6.4.2 Immunohaematology, Revenue (2004-2018) 67
6.4.3 Haemostasis, Revenue (2004-2018) 71
6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 75
6.4.5 Haematology Cell Counters, Revenue (2004-2018) 79
6.5 Haematology Distribution Share (2010-2011) 83
6.6 Haematology, India, Company Share (2010-2011) 84
7 Histology And Cytology In India 86
7.1 Histology and Cytology Market, Market Segmentation 86
7.2 Histology And Cytology Market, India, Revenue Mix ($m), 2011 87
7.3 Histology And Cytology Market, India, Segment Contribution (%), 2011 88
7.4 Histology And Cytology Overall Revenue, (2004-2018) 89
7.5 Histology And Cytology Distribution Share (2010-2011) 93
7.6 Histology And Cytology, India, Company Share (2010-2011) 94
8 Immuno Chemistry In India 96
8.1 Immuno Chemistry Market, India, Revenue Mix ($m), 2011 96
8.2 Immuno Chemistry Market, India, Segment Contribution (%), 2011 97
8.3 Immuno Chemistry Overall Revenue, (2004-2018) 99
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 103
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 107
8.3.3 Endocrinology Tests, Revenue (2004-2018) 111
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 115
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 119
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 125
8.4 Immuno Chemistry Distribution Share (2010-2011) 127
8.5 Immuno Chemistry, India, Company Share (2010-2011) 128
9 Infectious Immunology In India 130
9.1 Infectious Immunology, Market Segmentation 130
9.2 Infectious Immunology Market, India, Revenue Mix ($m), 2011 131
9.3 Infectious Immunology Market, India, Segment Contribution (%), 2011 132
9.4 Infectious Immunology Overall Revenue, (2004-2018) 133
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 137
9.5 Infectious Immunology Distribution Share (2010-2011) 141
9.6 Infectious Immunology, India, Company Share (2010-2011) 142
10 Microbiology Culture In India 144
10.1 Microbiology Culture, Market Segmentation 144
10.2 Microbiology Culture Market, India, Revenue Mix ($m), 2011 145
10.3 Microbiology Culture Market, India, Segment Contribution (%), 2011 146
10.4 Microbiology Culture Overall Revenue, (2004-2018) 147
10.4.1 Microbiology Analyzers, Revenue (2004-2018) 151
10.5 Microbiology Culture Distribution Share (2010-2011) 155
10.6 Microbiology Culture, India, Company Share (2010-2011) 156
11 Overview of Key Companies in India In Vitro Diagnostics Market 158
11.1 F. Hoffmann-La Roche Ltd. 158
11.1.1 Company Overview 158
11.1.2 Share in the India In Vitro Diagnostics Market 158
11.2 Transasia Bio-Medicals Ltd. 159
11.2.1 Company Overview 159
11.2.2 Share in the India In Vitro Diagnostics Market 159
11.3 Siemens Healthcare 160
11.3.1 Company Overview 160
11.3.2 Share in the India In Vitro Diagnostics Market 160
11.4 Beckman Coulter, Inc. 161
11.4.1 Company Overview 161
11.4.2 Share in the India In Vitro Diagnostics Market 161
11.5 Abbott Laboratories 162
11.5.1 Company Overview 162
11.5.2 Share in the India In Vitro Diagnostics Market 162
11.6 Span Diagnostics Ltd. 163
11.6.1 Company Overview 163
11.6.2 Share in the India In Vitro Diagnostics Market 163
11.7 Danaher Corporation 164
11.7.1 Company Overview 164
11.8 Sysmex Corporation 164
11.8.1 Company Overview 164
11.9 Becton, Dickinson and Company 165
11.9.1 Company Overview 165
11.10 Ortho-Clinical Diagnostics Inc. 165
11.10.1 Company Overview 165
11.11 Trivitron Healthcare Pvt Ltd. 165
11.11.1 Company Overview 165
11.12 Alere Inc. 166
11.12.1 Company Overview 166
11.13 Bio-Rad Laboratories, Inc. 166
11.13.1 Company Overview 166
11.14 Himedia Laboratories Pvt. Ltd. 167
11.14.1 Company Overview 167
11.15 Mindray Medical International Limited 167
11.15.1 Company Overview 167
11.16 Qiagen N.V. 168
11.16.1 Company Overview 168
11.17 Olympus Corporation 168
11.17.1 Company Overview 168
11.18 Agappe Diagnostics Ltd. 169
11.18.1 Company Overview 169
11.19 J.Mitra and Co. Pvt. Ltd. 169
11.19.1 Company Overview 169
11.20 Tulip Diagnostics (P) Ltd 169
11.20.1 Company Overview 169
11.21 bioMerieux S.A. 170
11.21.1 Company Overview 170
11.22 Gen-Probe Incorporated 170
11.22.1 Company Overview 170
11.23 Horiba, Ltd. 171
11.23.1 Company Overview 171
11.24 DiaSorin S.p.A 171
11.24.1 Company Overview 171
11.25 Thermo Fisher Scientific Inc. 172
11.25.1 Company Overview 172
11.26 Life Technologies Corporation 173
11.26.1 Company Overview 173
11.27 Hologic, Inc. 173
11.27.1 Company Overview 173
12 In Vitro Diagnostics Market Pipeline Products 174
12.1 Clinical Chemisty Market Pipeline Products 174
12.2 Immuno Chemistry Market Pipeline Products 177
12.3 Haematology Market Pipeline Products 186
12.4 Infectious Immunology Market Pipeline Products 188
12.5 Microbiology Culture Market Pipeline Products 195
12.6 Histology And Cytology Market Pipeline Products 196
12.7 Genetic Testing Market Pipeline Products 197
13 Financial Deals Landscape 202
13.1 Partnerships 202
13.1.1 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 202
13.1.2 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System 204
13.1.3 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 205
13.1.4 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 206
13.1.5 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 207
13.1.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 208
13.1.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology 210
13.1.8 CML HealthCare Enters Into Agreement With MaRS Innovation 211
13.1.9 Akrivis Technologies Enters Into Co-Development Agreement With United States Biological 212
13.1.10 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 213
13.1.11 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products 214
13.1.12 GVK Biosciences Enters Into Licensing Agreement With National Cancer Institute For GOBIOM Database 215
13.1.13 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina 216
13.1.14 DiaSorin Forms Joint Venture With Trivitron Healthcare 217
13.1.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 218
13.1.16 Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 219
13.1.17 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 220
13.1.18 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 221
13.1.19 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 222
13.1.20 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 223
13.1.21 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 224
13.1.22 One Lambda Enters Into Co-Marketing Agreement With CellTrend 225
13.1.23 Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 226
13.1.24 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 227
13.1.25 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 228
13.1.26 Everist Genomics Enters Into Joint Venture Agreement With Manipal Group 229
13.1.27 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 230
13.1.28 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 231
13.1.29 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 232
13.1.30 HealthLinx Enters Into Distribution Agreement With INEX Innovations Exchange And Metropolis Healthcare For OvPlex 233
13.1.31 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit 234
13.1.32 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 235
13.1.33 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology 236
13.1.34 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 237
13.1.35 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System 238
13.1.36 GE Healthcare Enters Into Research Agreement With Clino 239
13.1.37 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 240
13.1.38 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 241
13.1.39 Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 242
13.1.40 Avesthagen Enters Into Co-Development Agreement With CosmosID 243
14 Recent Developments 244
14.1 Strategy And Business Planning 244
14.1.1 Jun 04, 2012: Abbott India Opens Nutrition RandD Center In Collaboration With Syngene 244
14.2 Research And Development 244
14.2.1 Mar 08, 2012: Covidien Opens Four Global RandD Centers To Broaden Innovation Focus And Capabilities 244
14.3 Product News 245
14.3.1 Mar 27, 2012: BD And FIND Extend Pricing Agreement To Reach HIV-Positive Patients In India 245
14.3.2 Apr 25, 2011: Applied Visual Sciences Launches TBDxV TB Diagnostic Aid In India 245
15 Appendix 247
15.1 Definitions of Markets Covered in the Report 248
15.1.1 In Vitro Diagnostics 248
15.2 Research Methodology 260
15.3 Secondary Research 260
15.4 Primary Research 261
15.5 Models 261
15.6 Forecasts 262
15.7 Expert Panels 262
15.8 GlobalData Consulting 262
15.9 Currency Conversion 263
15.10 Contact Us 263
15.11 Disclaimer 263

List of Tables

Table 1: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018 19
Table 2: In Vitro Diagnostics Market, India, Category Contribution (%), 2011 21
Table 3: In Vitro Diagnostics Market, India, Cross-Category Analysis, 2004-2018 23
Table 4: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Table 5: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Table 6: In Vitro Diagnostics, India, Company Share by Revenue ($m), USD Constant, 2010-2011 29
Table 7: Clinical Chemistry Market, India, Segment Contribution (%), 2011 32
Table 8: Clinical Chemistry, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 34
Table 9: Clinical Chemistry, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 36
Table 10: Clinical Chemisty Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38
Table 11: Clinical Chemisty Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40
Table 12: Urine Analysis, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 41
Table 13: Urine Analysis, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 42
Table 14: Clinical Chemistry, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 15: Clinical Chemistry, India, Company Share by Revenue ($m), USD Constant, 2010-2011 45
Table 16: Genetic Testing Market, India, Segment Contribution (%), 2011 48
Table 17: Genetic Testing, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 50
Table 18: Genetic Testing, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 52
Table 19: Genetic Testing, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
Table 20: Genetic Testing, India, Company Share by Revenue ($m), USD Constant, 2010-2011 55
Table 21: Haematology Market, India, Segment Contribution (%), 2011 58
Table 22: Haematology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 60
Table 23: Haematology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 62
Table 24: Haematology Reagents, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 64
Table 25: Haematology Reagents, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 66
Table 26: Immunohaematology, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 68
Table 27: Immunohaematology, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 70
Table 28: Haemostasis, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 72
Table 29: Haemostasis, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 74
Table 30: Haematology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 76
Table 31: Haematology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 78
Table 32: Haematology Cell Counters, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 80
Table 33: Haematology Cell Counters, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 82
Table 34: Haematology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 83
Table 35: Haematology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 85
Table 36: Histology And Cytology Market, India, Segment Contribution (%), 2011 88
Table 37: Histology And Cytology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 90
Table 38: Histology And Cytology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 92
Table 39: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 93
Table 40: Histology And Cytology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 95
Table 41: Immuno Chemistry Market, India, Segment Contribution (%), 2011 98
Table 42: Immuno Chemistry, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 100
Table 43: Immuno Chemistry, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 102
Table 44: Disease Specific Immunochemistry, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 104
Table 45: Disease Specific Immunochemistry, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 106
Table 46: Drugs of Abuse / Toxicology, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 108
Table 47: Drugs of Abuse / Toxicology, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 110
Table 48: Endocrinology Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 112
Table 49: Endocrinology Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 114
Table 50: Immunochemistry Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2004-2011 116
Table 51: Immunochemistry Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 118
Table 52: Therapeutic Drug Monitoring, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 120
Table 53: Therapeutic Drug Monitoring, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 122
Table 54: Immunochemistry Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 124
Table 55: Immunochemistry Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 126
Table 56: Immuno Chemistry, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 127
Table 57: Immuno Chemistry, India, Company Share by Revenue ($m), USD Constant, 2010-2011 129
Table 58: Infectious Immunology Market, India, Segment Contribution (%), 2011 132
Table 59: Infectious Immunology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 134
Table 60: Infectious Immunology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 136
Table 61: Infectious Immunology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 138
Table 62: Infectious Immunology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 140
Table 63: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 141
Table 64: Infectious Immunology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 143
Table 65: Microbiology Culture Market, India, Segment Contribution (%), 2011 146
Table 66: Microbiology Culture, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 148
Table 67: Microbiology Culture, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 150
Table 68: Microbiology Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 152
Table 69: Microbiology Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 154
Table 70: Microbiology Culture, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 155
Table 71: Microbiology Culture, India, Company Share by Revenue ($m), USD Constant, 2010-2011 157
Table 72: Clinical Chemisty Market Pipeline Products 174
Table 73: Immuno Chemistry Market Pipeline Products 177
Table 74: Haematology Market Pipeline Products 186
Table 75: Infectious Immunology Market Pipeline Products 188
Table 76: Microbiology Culture Market Pipeline Products 195
Table 77: Histology And Cytology Market Pipeline Products 196
Table 78: Genetic Testing Market Pipeline Products 197
Table 79: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 202
Table 80: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System 204
Table 81: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 205
Table 82: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 206
Table 83: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 207
Table 84: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 208
Table 85: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology 210
Table 86: CML HealthCare Enters Into Agreement With MaRS Innovation 211
Table 87: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological 212
Table 88: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 213
Table 89: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products 214
Table 90: GVK Biosciences Enters Into Licensing Agreement With National Cancer Institute For GOBIOM Database 215
Table 91: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina 216
Table 92: DiaSorin Forms Joint Venture With Trivitron Healthcare 217
Table 93: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 218
Table 94: Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 219
Table 95: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 220
Table 96: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 221
Table 97: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 222
Table 98: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 223
Table 99: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 224
Table 100: One Lambda Enters Into Co-Marketing Agreement With CellTrend 225
Table 101: Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 226
Table 102: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 227
Table 103: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 228
Table 104: Everist Genomics Enters Into Joint Venture Agreement With Manipal Group 229
Table 105: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 230
Table 106: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 231
Table 107: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 232
Table 108: HealthLinx Enters Into Distribution Agreement With INEX Innovations Exchange And Metropolis Healthcare For OvPlex 233
Table 109: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit 234
Table 110: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 235
Table 111: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology 236
Table 112: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 237
Table 113: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System 238
Table 114: GE Healthcare Enters Into Research Agreement With Clino 239
Table 115: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 240
Table 116: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 241
Table 117: Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 242
Table 118: Avesthagen Enters Into Co-Development Agreement With CosmosID 243

List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 17
Figure 2: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018 18
Figure 3: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2011 20
Figure 4: In Vitro Diagnostics Market, India, Category Contribution (%), 2011 21
Figure 5: In Vitro Diagnostics Market, India, Cross-Category Analysis, 2004-2018 22
Figure 6: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24
Figure 7: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26
Figure 8: In Vitro Diagnostics, India, Company Share (%), 2011 28
Figure 9: Clinical Chemistry, Market Segmentation 30
Figure 10: Clinical Chemistry Market, India, Revenue Mix ($m), 2011 31
Figure 11: Clinical Chemistry Market, India, Segment Contribution (%), 2011 32
Figure 12: Clinical Chemistry, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 33
Figure 13: Clinical Chemistry, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35
Figure 14: Clinical Chemisty Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 37
Figure 15: Clinical Chemisty Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 39
Figure 16: Urine Analysis, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 41
Figure 17: Urine Analysis, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 42
Figure 18: Clinical Chemistry, India, Company Share (%), 2011 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, India, Revenue Mix ($m), 2011 47
Figure 21: Genetic Testing Market, India, Segment Contribution (%), 2011 48
Figure 22: Genetic Testing, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 49
Figure 23: Genetic Testing, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 51
Figure 24: Genetic Testing, India, Company Share (%), 2011 54
Figure 25: Haematology Market, Market Segmentation 56
Figure 26: Haematology Market, India, Revenue Mix ($m), 2011 57
Figure 27: Haematology Market, India, Segment Contribution (%), 2011 58
Figure 28: Haematology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 59
Figure 29: Haematology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 61
Figure 30: Haematology Reagents, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 63
Figure 31: Haematology Reagents, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 65
Figure 32: Immunohaematology, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 67
Figure 33: Immunohaematology, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 69
Figure 34: Haemostasis, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 71
Figure 35: Haemostasis, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 73
Figure 36: Haematology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 75
Figure 37: Haematology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 77
Figure 38: Haematology Cell Counters, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 79
Figure 39: Haematology Cell Counters, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 81
Figure 40: Haematology, India, Company Share (%), 2011 84
Figure 41: Histology and Cytology Market, Market Segmentation 86
Figure 42: Histology And Cytology Market, India, Revenue Mix ($m), 2011 87
Figure 43: Histology And Cytology Market, India, Segment Contribution (%), 2011 88
Figure 44: Histology And Cytology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 89
Figure 45: Histology And Cytology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 91
Figure 46: Histology And Cytology, India, Company Share (%), 2011 94
Figure 47: Immuno Chemistry Market, India, Revenue Mix ($m), 2011 96
Figure 48: Immuno Chemistry Market, India, Segment Contribution (%), 2011 97
Figure 49: Immuno Chemistry, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 99
Figure 50: Immuno Chemistry, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101
Figure 51: Disease Specific Immunochemistry, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 103
Figure 52: Disease Specific Immunochemistry, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 105
Figure 53: Drugs of Abuse / Toxicology, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 107
Figure 54: Drugs of Abuse / Toxicology, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 109
Figure 55: Endocrinology Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 111
Figure 56: Endocrinology Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 113
Figure 57: Immunochemistry Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2004-2011 115
Figure 58: Immunochemistry Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 117
Figure 59: Therapeutic Drug Monitoring, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 119
Figure 60: Therapeutic Drug Monitoring, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 121
Figure 61: Immunochemistry Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 123
Figure 62: Immunochemistry Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 125
Figure 63: Immuno Chemistry, India, Company Share (%), 2011 128
Figure 64: Infectious Immunology, Market Segmentation 130
Figure 65: Infectious Immunology Market, India, Revenue Mix ($m), 2011 131
Figure 66: Infectious Immunology Market, India, Segment Contribution (%), 2011 132
Figure 67: Infectious Immunology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 133
Figure 68: Infectious Immunology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 135
Figure 69: Infectious Immunology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 137
Figure 70: Infectious Immunology Rapid Tests, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 139
Figure 71: Infectious Immunology, India, Company Share (%), 2011 142
Figure 72: Microbiology Culture, Market Segmentation 144
Figure 73: Microbiology Culture Market, India, Revenue Mix ($m), 2011 145
Figure 74: Microbiology Culture Market, India, Segment Contribution (%), 2011 146
Figure 75: Microbiology Culture, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 147
Figure 76: Microbiology Culture, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 149
Figure 77: Microbiology Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 151
Figure 78: Microbiology Analyzers, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 153
Figure 79: Microbiology Culture, India, Company Share (%), 2011 156
Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),India In Vitro Diagnostics Market, 2011 158
Figure 81: Transasia Bio-Medicals Ltd., Company Share (%),India In Vitro Diagnostics Market, 2011 159
Figure 82: Siemens Healthcare, Company Share (%),India In Vitro Diagnostics Market, 2011 160
Figure 83: Beckman Coulter, Inc, Company Share (%),India In Vitro Diagnostics Market, 2011 161
Figure 84: Abbott Laboratories, Company Share (%),India In Vitro Diagnostics Market, 2011 162
Figure 85: Span Diagnostics Ltd., Company Share (%),India In Vitro Diagnostics Market, 2011 163

Companies mentioned

F. Hoffmann-La Roche Ltd.
Transasia Bio-Medicals Ltd.
Siemens Healthcare
Beckman Coulter, Inc.
Abbott Laboratories
Span Diagnostics Ltd.
Danaher Corporation
Sysmex Corporation
Becton, Dickinson and Company
Ortho-Clinical Diagnostics Inc.
Trivi

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.